Carbon starvation is one of the many stresses to which microbial pathogens are subjected while in the host. Pathways necessary for the utilization of alternative carbon sources, such as gluconeogenesis, the glyoxylate cycle, and -oxidation of fatty acids, have been shown to be required for full virulence in several systems, including the fungal pathogen Candida albicans. We have investigated the regulatory network governing alternative carbon metabolism in this organism through characterization of transcriptional regulators identified based on the model fungi, Saccharomyces cerevisiae and Aspergillus nidulans. C. albicans has homologs of the ScCAT8/AnFacB and ScADR1/AnAmdX transcription factors that regulate induction of genes encoding the proteins of gluconeogenesis, the glyoxylate cycle, and ethanol utilization. Surprisingly, C. albicans mutants lacking CAT8 or ADR1 have no apparent phenotypes and do not regulate genes for key enzymes of these pathways. Fatty acid degradation and peroxisomal biogenesis are controlled by nonhomologous regulators, OAF1/PIP2 in S. cerevisiae and FarA/FarB in A. nidulans; C. albicans is missing OAF1 and PIP2 and, instead, has a single homolog of the Far proteins, CTF1. We have shown that CTF1 is required for growth on lipids and for expression of genes necessary for -oxidation, such as FOX2. ctf1⌬/ctf1⌬ (ctf1⌬/⌬) strains do not, however, show the pleiotropic phenotypes observed for fox2⌬/⌬ mutants. The ctf1⌬/⌬ mutant confers a mild attenuation in virulence, like the fox2⌬/⌬ mutant. Thus, phenotypic and genotypic observations highlight important differences in the regulatory network for alternative carbon metabolism in C. albicans compared to the paradigms developed in other model fungi.Candida albicans is both a ubiquitous commensal of the human microbial flora and the most important fungal pathogen of humans (9, 43). While C. albicans can infect nearly any site in the body, the most serious manifestation, disseminated bloodstream infections, particularly affects immunocompromised individuals and is fatal in about 40% of cases (67). Candida species are responsible for ϳ9% of cases of hospitalacquired sepsis and up to 12% of central line-associated bloodstream infections, with C. albicans causing about half of these infections (23,67). Studying the biology of C. albicans in its natural niche, the mammalian host, provides insights into how this intriguing species has adapted to become such a successful pathogen and, as a result, is crucial to the development of new drug targets and treatment strategies.An increasing body of literature indicates that some host niches are carbon limited and that mutations that abrogate utilization of nonfermentable carbon sources are compromised in virulence models for many (but not all) fungal pathogens of both plants and animals, including C. albicans, Magnaporthe grisea, Leptosphaeria maculans, Stagonospora nodorum, and Colletotrichum lagenarium (2,5,27,33,46,48,59,66). In particular, studies have focused on the pathways of gluconeogenesis, the g...